| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/14/2009 | US7560449 Methods and therapeutic combinations for the treatment of demyelination |
| 07/14/2009 | US7560442 For prophylaxis and therapy of diabetes mellitus Type I and Type II, inflammation, cancer, necrosis, gastric ulcers, neurodegenerative diseases (Alzheimer's disease, Parkinson's disease), neuropathic diseases, neuropathic pain and polyneuropathy |
| 07/14/2009 | US7560425 Pharmaceutical composition consisting of rapamycine and gastrin 17(LEU15) and a method for treating diabetes |
| 07/14/2009 | US7560247 Nucleic acids encoding anti-IL-12 antibodies, and methods of production |
| 07/14/2009 | US7560105 Dendritic cells activated in the presence of glucocorticoid hormones are capable of suppressing antigen-specific T cell responses |
| 07/14/2009 | CA2439858C Graft rejection suppressors |
| 07/14/2009 | CA2403321C Amide compounds and use thereof |
| 07/09/2009 | WO2009086440A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | WO2009086439A2 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | WO2009086436A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | WO2009085177A1 Phenyl acetic acid derivatives as inflammation modulators |
| 07/09/2009 | WO2009084737A1 Compound having activity to suppress degranulation and cytokine production and use thereof |
| 07/09/2009 | WO2009084695A1 2-aminoquinazoline derivative |
| 07/09/2009 | WO2009084671A1 Human anti-α9 integrin antibody |
| 07/09/2009 | WO2009083738A2 Rna delivery vehicles |
| 07/09/2009 | WO2009043524A3 Use of a peptide as therapeutic agent |
| 07/09/2009 | WO2009033814A3 Use of the peptide combination thymosin beta 4 and delta sleep inducing peptide as a therapeutic agent |
| 07/09/2009 | WO2009033806A3 Use of gly-pro-glu-oh (gpe) as a therapeutic agent |
| 07/09/2009 | WO2009033764A3 Use of a peptide as a therapeutic agent |
| 07/09/2009 | WO2009033749A3 Use of thymopentin as a therapeutic agent |
| 07/09/2009 | WO2009033748A3 Use of osteostatin, alone or in combination with thymopentin, as a therapeutic agent |
| 07/09/2009 | WO2008138889A8 3, 6-disubstituted-imidazo [1, 2-b] pyridazines and 3, 5-disubstituted pyrazolo[1, 5-a] pyrimidines as phosphatidylinositol-3-kinase inhibitors |
| 07/09/2009 | WO2008132134A9 Novel antibody molecules and nucleic acids binding to fungal stress protein hsp90 |
| 07/09/2009 | WO2008052468A8 New lactobacillus rhamnosus strain, its pharmaceutical composition and the uses thereof, and the method for preparation |
| 07/09/2009 | US20090176973 Thrombopoietin mimetics |
| 07/09/2009 | US20090176880 Methods for Culturing Human Lung Mast Cells and Uses Thereof |
| 07/09/2009 | US20090176879 Fatty acid desaturases from primula |
| 07/09/2009 | US20090176864 Methods For Improving Hepatic and Immune Function In An Animal |
| 07/09/2009 | US20090176853 Adamantane derivatives |
| 07/09/2009 | US20090176806 protein kinase C or glycogen synthase kinase-3-beta inhibitors such as 3-(2-chlorophenyl)-4-[1-(3-hydroxypropyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]-1H-pyrrole-2,5-dione, used for treating cardiovascular, skin, nervous system disorders and immunological disorders, diabetes, inflammatory diseases and cancer |
| 07/09/2009 | US20090176804 2-phenyl-indoles as prostaglandin d2 receptor antagonists |
| 07/09/2009 | US20090176799 Phosphodiesterase 4 inhibitors |
| 07/09/2009 | US20090176775 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 07/09/2009 | US20090176763 Azaindoles useful as inhibitors of JAK and other protein kinases |
| 07/09/2009 | US20090176746 4'-{N'-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-1,5-dihydropyrazol-4-ylidene]hydrazino}-3'-hydroxybiphenyl-4-carboxylic acid; Promotes thrombopoiesis and megakaryocytopoiesis |
| 07/09/2009 | US20090176707 Human signal peptide-containing proteins |
| 07/09/2009 | US20090176701 Anti-microbial agents that interact with the complement system |
| 07/09/2009 | US20090175951 Nanoparticulate compositions of immunosuppressive agents |
| 07/09/2009 | US20090175912 chimeric proteins; immunogens; from non-typeable Haemophilus influenzae or Moraxella catarrhalis, provides protective antigens in single molecule; inserting into surface exposed loops improves detection by immune system |
| 07/09/2009 | US20090175909 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175903 Measles subunit vaccine |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175881 Interleukin-17A specific immunoglobulin for use in prevention and treatment of inflammatory, autoimmune and proliferative disorders |
| 07/09/2009 | US20090175879 Novel target in the treatment of cytokine release syndrome |
| 07/09/2009 | US20090175859 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease |
| 07/09/2009 | US20090175855 Novel compositions and methods for the treatment of immune related diseases |
| 07/09/2009 | US20090175823 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 07/09/2009 | US20090175819 Molecule and chimeric molecules thereof |
| 07/09/2009 | US20090175798 Mycobacterial Catalase-Peroxidase in the Diagnosis and Treatment of Sarcoidosis |
| 07/09/2009 | US20090175797 Inflammation-Inhibitory Serum Factors and Uses Thereof |
| 07/09/2009 | CA2710977A1 2-methylene-20-methyl-19,24,25,26,27-pentanor-vitamin d analogs |
| 07/09/2009 | CA2710974A1 2-methylene-(20s,25s)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710970A1 2-methylene-(20s,25r)-19,26-dinor-vitamin d analogs |
| 07/09/2009 | CA2710966A1 (20r)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | CA2710954A1 (20s)-23,23-difluoro-2-methylene-19-nor-bishomopregnacalciferol-vitamin d analogs |
| 07/09/2009 | CA2707789A1 Phenyl acetic acid derivatives as inflammation modulators |
| 07/08/2009 | EP2077325A1 Monoclonal antibody and use thereof |
| 07/08/2009 | EP2077279A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 07/08/2009 | EP2077277A1 Use of mammalian cytokine; related reagents |
| 07/08/2009 | EP2077120A2 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 07/08/2009 | EP2077117A1 Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases |
| 07/08/2009 | EP2076596A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/08/2009 | EP2076539A2 Antibody molecules which bind il-17a and il-17f |
| 07/08/2009 | EP1732588B1 Modulation of nkg2d |
| 07/08/2009 | EP1539933A4 Methods of organ regeneration |
| 07/08/2009 | EP1495022B1 Diazabicyclo alkane derivatives with nk1 antagonistic activity |
| 07/08/2009 | EP1383927B1 New polynucleotides and polypeptides of the erythropoietin gene |
| 07/08/2009 | EP1371730B1 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 07/08/2009 | EP1232175B1 Method of forming a peptide-receptor complex with zsig33 polypeptides. |
| 07/08/2009 | EP1009429B1 Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient |
| 07/08/2009 | CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof |
| 07/08/2009 | CN100510073C Tryptase inhibitor |
| 07/08/2009 | CN100510068C A soluble complex comprising a retroviral surface glycoprotein |
| 07/08/2009 | CN100510060C Method of extended culture for antigen-specific cytotoxic t lymphocytes |
| 07/08/2009 | CN100509846C Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells |
| 07/08/2009 | CN100509843C Acid-modified arabinogalactan protein composition |
| 07/08/2009 | CN100509811C Azaindoles |
| 07/08/2009 | CN100509810C Substituted beta-carbolines |
| 07/08/2009 | CN100509805C 3,4-dihydro-1h-isoquinoloin-2-yl-derivatives |
| 07/08/2009 | CN100508978C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors |
| 07/08/2009 | CN100508975C Use of pyrazolopyridine compound |
| 07/08/2009 | CN100508965C Dosage forms having prolonged active ingredient release |
| 07/07/2009 | US7557212 Tricyclic derivatives as LTD4 antagonists |
| 07/07/2009 | US7557210 Antiinflamamtory agents |
| 07/07/2009 | US7557139 Triptolide analogs for the treatment of autoimmune and inflammatory disorders |
| 07/07/2009 | US7557128 Having antiallergic and anti-inflammatory effects while being devoid of the severe dose-limiting sedative side effects of ketotifen |
| 07/07/2009 | US7557110 Pyrazolo[1,5-A] pyrimidine derivatives |
| 07/07/2009 | US7557106 inhibitors of FLT-3, Aurora-1, Aurora-2, and Aurora-3 protein kinases; leukemia; N-{4-[4-(5-Methyl-2H-pyrazol-3-ylmethyl)-6-(4-propyl-piperazin-1-yl)-pyrim- idin-2-ylsulfanyl]-phenyl}-propionamide |
| 07/07/2009 | US7556965 Structural protein of adeno-associated virus with modified antigenicity, its production and its use |
| 07/07/2009 | US7556957 Attenuated virus-like particle for use as gene transfer tool in treatment and prevention of metabolic disorders; tissue target therapy |
| 07/07/2009 | US7556803 Using kappa-myeloma antigen specific immunoglobulins to target and destroy tumor cells; immunotherapy |
| 07/07/2009 | CA2486101C Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 07/07/2009 | CA2450033C Viral polymerase inhibitors |
| 07/07/2009 | CA2378834C Pyrazinones, compositions containing such compounds |
| 07/07/2009 | CA2201161C Isolated nucleic acid molecule coding for tumor rejection antigen precursor dage and uses thereof |
| 07/02/2009 | WO2009082720A2 Substituted 4-{3-[6-amino-9-(3,4-dihydroxy-tetrahydro-furan-2-yl)-9h-purin-2-yl]-prop-2-ynyl}-piperidine-1-carboxylic acid esters as a2ar agonists |
| 07/02/2009 | WO2009082342A1 Steroid derivatives acting as glucocorticosteroid receptor agonists |
| 07/02/2009 | WO2009080934A2 Allergen desensitization method |
| 07/02/2009 | WO2009080744A1 Crystalline form of azelastine |
| 07/02/2009 | WO2009080730A1 1, 2, 4 -oxadiazole compounds for the treatment of autoimmune diseases |